Vergoeding 2018-2022 voor ATC-subgroep N05AX : Overige antipsychotica
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| N05AX08 Risperidon (Risperdal ®) | 4.643.700 | 4.612.300 | 4.463.300 | 3.771.500 | 3.572.100 |
| N05AX12 Aripiprazol (Abilify maintena ®) | 10.436.100 | 11.191.100 | 11.732.300 | 11.690.900 | 13.966.800 |
| N05AX13 Paliperidon (Xeplion ®) | 10.571.000 | 11.772.500 | 12.625.400 | 12.704.300 | 13.354.700 |
| N05AX15 Cariprazine (Reagila ®) | 4.180 | 151.150 | 338.960 | 376.650 | 473.400 |
| N05AX16 Brexpiprazol (Rxulti ®) | . | 37.899 | 162.690 | 205.840 | 224.350 |
| Totaal | 25.654.980 | 27.764.949 | 29.322.650 | 28.749.190 | 31.591.350 |